or over 20 years, determination of carotid bulb sources of stroke (carotid-source stroke) has been based primarily on lumen stenosis. In 1991, the North American Symptomatic Carotid Endarterectomy Trial (NASCET) cemented the role of carotid stenosis as a stroke predictor, leading to our current approach for intervention.
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January 2015 stenosis and both much more accurate than duplex ultrasound. 6 Carotid plaque ulceration has long been an indicator for surgery but can be difficult to detect with DSA. 7 Ulceration can be detected with CTA at a threshold of ≥2 mm with high sensitivity (87%) and specificity (99%) compared with histology. 8 Intraluminal thrombus is an additional lumen marker highly associated with stroke and can be detected on CTA as a donut sign. 9 Despite these advances, stenosis remains the primary measurement to determine carotid sources of stroke, future stroke risk, and potential benefit of surgical versus medical therapy.
In the early 2000s, high carotid wall signal on MRI was first shown to detect complex atheromas by Moody et al. 10 Recently, MRI sequences including the heavily T1-weighted magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence have been used to detect intraplaque hemorrhage (IPH) and are much more sensitive and specific compared with conventional time-of-flight (TOF) and T1-weighted images.
11 MPRAGE-positive plaque is now an additional predictor of carotid-source stroke, with increased stroke risk for all degrees of stenosis. [12] [13] [14] Still, it is unclear whether IPH is only a surrogate for other markers of unstable plaque, including plaque thickness, ulceration, or intraluminal thrombus. Recent research suggests that CTA-detected ulceration may be used as a surrogate for IPH. 15 If ulceration or other lumen markers could be used as true surrogates for IPH, carotid MRI may not add significant value in detecting stroke sources. Until now, however, no studies have addressed the relative contributions of IPH along with all other available imaging and clinical markers of stroke risk in a multivariable analysis.
With this in mind, our goal was to determine which carotid imaging characteristics best predict ipsilateral carotid-source stroke. We initiated the MPRAGE sequence as part of the clinical protocol in November 2009. The data were gathered and analyzed retrospectively, as a cross-sectional study. Our hypothesis was that IPH would be an essential imaging marker of stroke, even after controlling for known clinical and imaging markers of stroke risk. To evaluate the potential importance of carotid IPH, we included all patients undergoing acute stroke workup with carotid MRA over the course of 4.5 years. Using a multivariable logistic regression model, essential imaging and clinical markers of carotid-source stroke were determined.
Methods

Clinical Study Design
Institutional review board approval was obtained for this retrospective cross-sectional study on patients undergoing stroke evaluation with brain MRI/carotid MRA at the University of Utah Medical Center from November 2009 to January 2014. The carotid MPRAGE sequence was obtained in all patients (578) undergoing carotid MRA stroke workup beginning in November 2009. All patients were scanned within 1 week of symptom onset. This resulted in 1156 carotid artery-ipsilateral brain image pairs.
Exclusions were determined after reviewing electronic medical records for noncarotid plaque stroke sources, those outside of the 2 cm above and 2 cm below the carotid bifurcation. A total of 420 carotidbrain pairs were excluded, including craniocervical dissections (118), atrial fibrillation (94), intracardiac/extracardiac shunt (86), cardiac thrombus (26), recent aortic or mitral valve replacement (16) , vasculitis (14) , global hypoxic/ischemic injury (10), recent cardiac or neurovascular catheterization (10), recent cardiovascular surgery (8) , dural venous sinus thrombosis (8) , fibromuscular dysplasia or lupus vasculopathy (8) , proximal carotid stenosis >50% (6), rheumatic heart disease (4), brain neoplasm (4), endocarditis (2), idiopathic hypertrophic subaortic stenosis (2), aortic graft complication (2) , and distal vessel atherosclerosis (2) . We also excluded carotid occlusions (7) and nearocclusions (3) because lumen markers cannot accurately be assessed. Seven hundred twenty-six carotid-brain image pairs were used in the final analysis. Although a few scans exhibited mild motion artifacts primarily from swallowing, these artifacts were not sufficient to exclude any carotid images from interpretation.
MRI/MRA Clinical Protocol
Images were obtained on Siemens 3-T and 1. 
Carotid MPRAGE Sequence
MPRAGE parameters were first optimized at 3T and were as follows: 3D, repetition time/echo time/time to inversion=6.39/2.37/370 ms, flip angle=15°, field of view=130×130×48 mm3, matrix=256×256×48, voxel=0.5×0.5×1.0 mm3, fat saturation, time ≈5 minutes. The time to inversion was initially optimized for 3T and transferred to 1.5T. An initial time to inversion of ≈500 ms was chosen based on prior computer simulations at 3T and was adjusted down to a time to inversion of 370 ms to maximize contrast between hemorrhage and inflowing blood in human volunteers as described previously. 16, 17 Images were obtained from 20 mm below to 20 mm above the carotid bifurcation at 1.0 mm slice thickness. To produce 3D images, a secondary phase encoding gradient was used in the slice select direction, and measurements for all slice selection phase encodings were performed with rapid acquisition in each segment.
Imaging Markers of Carotid-Source Stroke
All carotid imaging markers were determined by consensus review of 2 reviewers (J.S.M. and M.S.M.), blinded to brain MRI findings and clinical covariates. In addition, IPH was determined independent of other carotid imaging markers of stroke risk. Lumen markers included stenosis, maximum plaque thickness, ulceration, and intraluminal thrombus.
Percent diameter stenosis was determined using NASCET criteria on contrast MRA, using the formula [(a−b)/a]×100% where (b) is the diameter of maximal stenosis and (a) is the diameter of the ICA distal to the stenosis. Carotid stenosis was measured at the narrowest segment of the carotid plaque (b) on the axial images, perpendicular to the long axis of the vessel on multiplanar reformats using a submm measurement tool ( Figure 1A ). The distal ICA diameter (a) was measured beyond the bulb where the walls are parallel and no longer tapering per NASCET. [2] [3] [4] We performed the multivariable regression analysis using both NASCET stenosis [(a−b)/a]×100% and mm stenosis (b), adapted from the mm stenosis method first described on CTA. 18 Near-occlusions were defined using the following criteria: visible bulb stenosis, distal ICA diameter ≤3 mm, and distal ICA/distal external carotid artery ratio of ≤1.25. These criteria were adapted from Bartlett et al 18 to recognize near-occlusions on CTA, and originally adapted from DSA.
Ulceration was determined on contrast MRA images using a size threshold of 2 mm, previously described with CTA. 15 Intraluminal thrombus was determined using contrast MRA multiplanar reformats and defined by a noncontrast filling defect outlined by lumen contrast. On axial images, this often manifests as a donut sign, previously described on CTA. 9 Each of the 19 subjects with intraluminal thrombus had a contrast MRA study. Moreover, the majority of these patients had confirmation with another imaging method CTA (15), DSA (1), or ultrasound (1). In arteries from patients with renal failure (glomerular filtration rate <30 mL/min per 1.73 m 2 , 68/726 or 9.4% of carotid-brain image pairs), the above imaging markers were determined from 3D noncontrast TOF with 1 mm slice thickness combined with duplex ultrasound. Maximum plaque thickness was measured in the transverse plane on MPRAGE images. IPH was defined quantitatively as MPRAGE-positive plaque, with ≥1 voxel with ≥2-fold higher signal intensity relative to adjacent sternocleidomastoid muscle as previously described.
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Acute Stroke Determination
Recent carotid territory infarct was defined using the DWI technique derived from diffusion tensor imaging (DTI) trace images from our standard clinical imaging protocol, as previously described. 12 DTI trace images have been shown to be superior to conventional diffusion-weighted sequences in detecting recent infarcts. 19 Briefly, DTI parameters were 2D, 128×128 matrix, 3 mm slice thickness, B value=2000, 22 directions. Although the referring clinician suspected a possible recent infarct, only objective DWI images were used to determine if a recent infarct was present. DWI positivity was defined as hyper intense signal on DTI trace corresponding to a recent infarct at the time of the scan. 20, 21 Embolic infarcts were defined as those involving the cortex or subcortical white matter, whereas microvascular infarcts were defined as those involving only the basal ganglia or adjacent white matter. Only DWI positive embolic infarcts in the ipsilateral ICA territory were placed in the DWI positive category and presumably represented carotid-source strokes after excluding other stroke sources under our clinical study design. Brain DWI images were interpreted by a subspecialty trained, certificate of added qualification-certified neuroradiologist blinded to carotid imaging.
Statistical Analysis
A mixed effects multivariable logistic regression model was used and accounted for 2 vessels per patient. The multivariable logistic regression model was fitted for the outcome of ipsilateral stroke. Carotid imaging predictors included stenosis, maximum plaque thickness, ulceration, intraluminal thrombus, and IPH. Clinical covariates included age, male sex, diabetes mellitus, hypertension, hyperlipidemia, and body mass index. Cardiovascular medication confounders included antihypertension, antiplatelet, anticoagulation, and statin medication classes. Magnet strength (3T or 1.5T) was also included as a potential confounder in the logistic regression model. A backwards elimination method was used to determine the final model, in which all remaining predictors had a P<0. 10 . Odds ratios (ORs) and P values were reported for each factor alone and for the factors found to be significant from the backward elimination. Receiver operating characteristic comparison analysis was performed to determine the discriminatory value of the final model (with IPH) compared with (1) the final model without IPH, (2) a model using only percent stenosis as a continuous variable, and (3) a model using only percent stenosis with standard clinical cutoffs of 50% and 70%. All statistical analyses were performed with Stata version 13.1.
Results
Patient Demographics
Patient demographics are listed by vessel and depicted in Table 1 .
Carotid Plaque Markers and Stroke Imaging
The carotid plaque features measured in this study included percent diameter stenosis, mm stenosis, maximum plaque thickness, ulceration, intraluminal thrombus, and IPH. Carotid stenosis was measured using percent diameter stenosis [(a−b)/a]×100% and mm stenosis (b) in Figure 1A . Ulceration was determined on contrast MRA images using a 2 mm measurement threshold in Figure 1B . Intraluminal thrombus was defined as a filling defect on contrast MRA images in Figure 1C . Maximum plaque thickness was measured in the transverse plane on 3D MPRAGE images in Figure 1D . IPH was defined by MPRAGE-positive plaque, using a signal threshold of 2-fold signal intensity over adjacent sternocleidomastoid muscle in Figure 1D , with an MPRAGE-positive right carotid plaque, image left. Recent carotid territory embolic stroke was defined using DWI (DTI trace) in Figure 2 . 
Multivariable Logistic Regression
Carotid-source stroke predictors are depicted in Table 2 , with ORs adjusted using multivariable logistic regression.
Final Multivariable Logistic Regression Model
The final model for predictors of carotid-source stroke is depicted in 
Receiver Operating Characteristic Comparison Analysis
Receiver operating characteristic comparison analysis is shown in Figure 3 
Discussion
Determining stroke pathogenesis is critically important because treatment directed at stroke sources can prevent future stroke. This study is the first to demonstrate that IPH adds significant discrimination of carotid-source stroke even when using all available lumen markers (stenosis, thickness, ulceration, and intraluminal thrombus). These results suggest that carotid MRI and IPH detection be used in the determination of stroke sources. Currently, CTA use far outweighs the use of MRA and is used ≈4× as often as MRA at our institution. Although CTA has a higher resolution than MRA, both detect lumen stenosis with a similar, high accuracy compared with DSA. 6 In addition, plaque density on CTA is a poor IPH predictor. 15 It is clear from this research that stroke source workup is incomplete if one uses only lumen information from CTA or MRA without IPH-sensitive sequences, such as MPRAGE.
Of potential concern with CT stroke workup is radiation dose, given the carcinogenesis risk extrapolated from other studies. Over the past 30 years, medical radiation sources have increased the average radiation dose per person in the United States from an average of 3.6 mSv in the 1980s to 6.2 mSv in 2006. 22, 23 Extrapolating data from Hiroshima, Three Mile Island, Chernobyl, and radiation workers to current CT use, it has been estimated that 1.5% to 2.0% of all cancers in the United States may be attributable to CT radiation. 24 Acute stroke workup with CT/CTA/CT perfusion results in a mean effective dose of 16.4 mSv, imparting a low cancer risk of 1 in 1200 patients. 25 Effective dose is calculated from the dose length product (mGycm) taking into account the radiosensitivity of imaged organs, 80% of which is attributed to the thyroid. 26 One reason for this low risk is that most patients undergoing stroke workup are within the sixth to ninth decades, and exposure in this age group carries a low risk of excess cancer mortality because of decreased dose length product conversion factors. Although the individual risk of cancer with CT stroke workup seems to be small, databases have been developed for future large-scale epidemiological studies addressing CT-radiation risk. 27 Although both intraluminal thrombus and IPH were required for optimal stroke-source determination in our final regression model, IPH added no further discriminatory value in the relatively rare instance of intraluminal thrombus detection. These findings are perplexing because carotid-source stroke has always been understood to occur by initial thrombus formation and subsequent fragmentation and embolic stroke. These thrombi likely also form with IPH, but they may be below the limits of detection or they may have already embolized to the brain. Confirmation of IPH-induced microthrombi could be obtained with future studies using high-resolution methods including optical coherence tomography. 28 The explanation for the increased stroke risk with IPH may be multifactorial. IPH is thought to result from plaque microvessel leakage and may be a marker of inflamed plaque with endothelial dysfunction. IPH may also directly contribute to plaque inflammation through iron deposition and reactive oxygen species formation. 29 In addition, IPH has been shown to increase rapidly plaque size and stenosis. 30 This can result in pathological changes in endothelial mechanotransduction related to oscillatory shear stress, resulting in endothelial oxidative stress, inflammation, and contributing to stroke risk. 31 Maximum plaque thickness retained significance in the final model, indicating further risk not explained by intraluminal thrombus or IPH. This suggests that IPH volume or other markers may be additional predictors of stroke risk. Possibilities include a thinned or ruptured fibrous cap or lipid rich necrotic cores, both of which can be detected by delayed postcontrastenhanced images. 32 These factors and others may allow further discriminatory value in the detection of carotid-source strokes.
Interestingly, our data suggest that current smoking adds further discrimination of carotid-source strokes. Current smoking may cause active inflammation unaccounted for by IPH, intraluminal thrombus, or plaque thickness. Smokers have increased carotid plaque neovascularity and permeability as measured by K trans , the contrast transfer constant, now detectable with dynamic contrast enhanced-MRI. 33, 34 It is well established that current smoking activates a proembolic component of carotid plaque. 35 Evidence suggests that smoking results in platelet activation and thrombogenesis in atherosclerotic plaque. 36 Our data further support the role of current smoking in thromboembolism from carotid stroke sources.
Despite our recent research demonstrating a significant difference between 3-T and 1.5-T MPRAGE image quality and intraobserver and interobserver agreement, magnet strength did not significantly confound the association of IPH and stroke. This is likely because the effect of magnet strength on gross MPRAGE positive or negative status is small, on the order of 10% in our recent study. 37 In addition, 3-T magnets are used far less often than 1.5-T magnets in the evaluation of acute stroke at our institution. The results of this study further suggest that IPH detection can and should be used as part of stroke source workup at both magnet strengths.
Although these data are somewhat limited because of their cross-sectional nature, they nonetheless argue against using only stenosis to determine carotid stroke sources. With advances in imaging, evidence supporting stroke risk stratification based on IPH is rapidly accumulating. [38] [39] [40] Furthermore, our data suggest that MRA-detected ulceration is not a significant determinate of carotid-source stroke when IPH is taken into account. One limitation in our study, however, is that histological validation was not possible and small ulcerations may have been missed. This is a consequence of our study's main objective, to determine lumen markers visible by MRA. Nonetheless, our data suggest that ≥2 mm ulcerations should not be used as a replacement for IPH as was suggested by a recent CTA study. 15 One difference between the 2 studies is that our study accounted for other markers of unstable carotid plaque including intraluminal thrombus, plaque thickness, and clinical markers including current smoking. Another explanation may be that MRA is detecting both calcified and noncalcified ulcerations, whereas CTA separately identifies noncalcified ulcerations. If this is the case, then only noncalcified ulcerations may be associated with IPH and stroke risk. Future studies can be designed to answer this important question.
Summary
Optimal discrimination of carotid-source stroke required information on IPH, intraluminal thrombus, maximum plaque thickness, and smoking history. Ulceration and stenosis do not contribute when other imaging and clinical factors are taken into account. These data suggest that carotid MRI and IPH detection be used in carotid-source stroke workup.
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